Biotechnology Executive
Regeneron Pharmaceuticals
Jonathon Whitton, AuD, PhD is the Global Program Head for the Auditory Therapeutic Area at Regeneron Genetic Medicines. Prior to that, he was a co-founder and CEO of Source Bio, an early stage biotechnology company developing advanced gene therapy technologies and was part of the early team that built Decibel Therapeutics, where he served as the Head of Clinical Research and Development. Jonathon is a clinician-scientist and inventor of several gene therapy technologies. He has been invovled in translational and clinical research for deafness and balance loss for nearly two decades. Jonathon received his Ph.D. from the Massachusetts Institute of Technology and his Au.D. from the University of Louisville.
Thursday, April 18, 2024
4:45 PM – 5:45 PM EST
Disclosure(s): No financial or nonfinancial relationships to disclose.